Culture medium and culture method applied to breast cancer organoid of patient after chemotherapy
By using specific combinations of culture media and treatment steps, the problem of breast cancer organoid culture after chemotherapy was successfully solved, the success rate and cell morphology were improved, and its value in clinical research and application was expanded.
Patent Information
- Application Number
- CN202411017793.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-29
- Publication Date
- 2024-11-12
AI Technical Summary
The prior art is difficult to effectively culture breast cancer organoids in patients after chemotherapy, resulting in low culture success rate and irregular cell morphology, limiting its value in clinical research and application.
A type of recombinant protein R-Spondin 3, head protein Noggin, cell growth factor, B27 additive, inhibitor, nicotinamide, acetylcysteine N-Acetylcysteine, SOX2, CHIR99021 and recombinant were used The culture medium of protein Wnt3a, combined with specific cell processing steps, forms breast cancer organoids.
It improves the success rate of breast cancer organoid culture, forms spherical cell formation, short culture cycle, retains the heterogeneity of the patient's source tissue, reduces the culture cost, and provides accurate drug guidance for drug screening for patients after chemotherapy.
Smart Images

Figure CN118931840A_ABST
